Home > Result Summaries: Compounds > otelixizumab > Result Summary for 113390

Result Summary for 113390

Result Summary

Protocol ID:	113390
Clinical Study ID:	OTX113390
Official Title:	Evaluation of the safety and tolerability of re-dosing with intravenous (iv) otelixizumab in adult subjects with newly diagnosed type 1 diabetes mellitus
Phase:	phase 2
Study Indications or Diseases:	Diabetes Mellitus, Type 1
Generic Name:	otelixizumab
Trade/Product Name:	otelixizumab
Approved Drug Label:	http://www.gsk.com/products.html
Results Summary:	Click here to download result summary.
Citations:	GSK has concluded that it is not feasible to publish this study in a peer-reviewed scientific journal because the nature of the study is unlikely to be of interest to a journal. GSK is providing the attached study results summary with a conclusion.